ArticleHuman gene therapy. Clinical development2016

Investor Outlook: Rising from the Ashes; GSK's European Approval of Strimvelis for ADA-SCID.

Joshua Schimmer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.